MoonLake Immunotherapeutics - Ordinary Shares - Class A
MLTX
Market Cap$3.48B
Close$
$2.82
92.9% downside
Current Fair Value
92.9% downsideOvervalued by 92.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.48 Billion |
|---|---|
| Enterprise Value | $3.30 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.73 |
| Beta | 1.26 |
| Outstanding Shares | 62,874,637 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -63.42 |
|---|---|
| PEG | -22.56 |
| Price to Sales | - |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 167166.23 |
| Enterprise Value to EBIT | -34.53 |
| Enterprise Value to Net Income | -41 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data